| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/13543770903338768 |
| P698 | PubMed publication ID | 19874257 |
| P2093 | author name string | Aher Nilkanth Ganpat | |
| Deshpande Sunita Ranjan | |||
| Pore Vandana Sudhir | |||
| P2860 | cites work | The evolving role of natural products in drug discovery | Q28236671 |
| The epidemiology of sepsis in the United States from 1979 through 2000 | Q29547760 | ||
| Comprehensive essential gene identification as a platform for novel anti-infective drug discovery. | Q31070591 | ||
| Recent advances in antifungal agents | Q31131154 | ||
| Phomoxanthones A and B, novel xanthone dimers from the endophytic fungus Phomopsis species | Q34087963 | ||
| Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery | Q34264835 | ||
| New mono- and dimeric members of the secalonic acid family: blennolides A-G isolated from the fungus Blennoria sp. | Q34772116 | ||
| Microbial natural products as a source of antifungals | Q35105782 | ||
| Recent advances in antifungal pharmacotherapy for invasive fungal infections | Q35917383 | ||
| New developments in antifungal strategy | Q35917388 | ||
| Amphotericin B. | Q36094404 | ||
| Caspofungin: a review of its use in the treatment of fungal infections | Q36257157 | ||
| Emerging echinocandins for treatment of invasive fungal infections | Q36458402 | ||
| Current advances in antifungal targets and drug development | Q36483030 | ||
| Recent advances in antifungal chemotherapy | Q36831347 | ||
| Micafungin for the prophylaxis and treatment of Candida infections | Q37124868 | ||
| New agents to treat life-threatening fungal infections | Q37161016 | ||
| Echinocandins: a wealth of choice--how clinically different are they? | Q37204856 | ||
| Recent approaches to antifungal therapy for invasive mycoses. | Q37377752 | ||
| The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis | Q37425218 | ||
| Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009). | Q37492735 | ||
| Screening of natural products for antimicrobial agents. | Q37977577 | ||
| PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. | Q43640900 | ||
| Antimicrobial activities of N-(2-hydroxy-1-naphthalidene)-amino acid(glycine, alanine, phenylalanine, histidine, tryptophane) Schiff bases and their manganese(III) complexes | Q44847479 | ||
| Distribution of the antifungal agents sordarins across filamentous fungi | Q45032845 | ||
| Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation. | Q46608392 | ||
| X-ray Structure Determination, Absolute Configuration and Biological Activity of Phomoxanthone A | Q53606626 | ||
| Application of affinity selection/mass spectrometry to determine the structural isomer of parnafungins responsible for binding polyadenosine polymerase. | Q54784040 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 137-143 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Expert Opinion on Therapeutic Patents | Q5421213 |
| P1476 | title | Antifungal agents, WO2009025733. | |
| P478 | volume | 20 |
| Q42285275 | Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. | cites work | P2860 |
Search more.